
Scil Proteins
Advanced protein engineering solutions for biopharma and life sciences, enhancing drug development and therapeutic innovations.
Date | Investors | Amount | Round |
---|---|---|---|
€24.0m | Late VC | ||
Total Funding | 000k |
Related Content
Scil Proteins is a specialized company focused on providing advanced protein engineering solutions to the biopharma and life sciences sectors. The company operates in the biotechnology market, serving clients that include pharmaceutical companies, research institutions, and healthcare providers. Scil Proteins' business model revolves around offering customized protein engineering services, which include protein design, production, and optimization. These services are crucial for drug development, therapeutic innovations, and various biotechnological applications. The company generates revenue through service contracts, research collaborations, and licensing agreements. By leveraging cutting-edge technologies such as artificial intelligence and cloud computing, Scil Proteins ensures efficient data management and innovative solutions for its clients. The company is also involved in educational initiatives, such as the Rainer Rudolph Foundation, which aims to nurture young talents in protein biotechnology.
Keywords: protein engineering, biopharma, life sciences, drug development, therapeutic innovations, biotechnology, AI, cloud computing, research collaborations, educational initiatives.